Skip to content
Open in App
ABL Bio logo

ABL Bio

web2

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for i...

Symbol · 298380
Company profile

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company offers ABL301, which is in the phase 1 clinical stage for the treatment of parkinson’s disease; ABL503 and ABL111 that is in phase 1 clinical stage for the treatment of solid tumor; and ABL102 for the treatment of solid and blood tumor. It also provides ABL103 for the treatment solid cancers; ABL104 for the treatment of solid tumor; and ABL105, which is in phase 1 clinical stage for the treatment of solid tumor. ABL Bio Inc. was incorporated in 2016 and is based in Seoul, South Korea.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeKOSDAQPrimary symbol: 298380
Expert coverage

1 expert evaluated ABL Bio.

Orbitrum research

Experts evaluating ABL Bio

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment